JONATHAN SMITH: Open Payments
NPI 1932522547 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,479 in 34 payments from 13 companies in 2025. Trend: 2023 $51 · 2024 $0 · 2025 $1,479
Food & beverage: $1,004Consulting: $475
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 3 | $642 |
| United Therapeutics Corporation | 3 | $206 |
| GlaxoSmithKline, LLC. | 12 | $157 |
| Grifols USA, LLC | 4 | $136 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $126 |
| Amgen Inc. | 2 | $48 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| Insmed, Inc. | 1 | $25 |
| Baxter Healthcare | 1 | $24 |
| Breas Medical, Inc. | 1 | $24 |
Products named: Ohtuvayre, NUCALA, Prolastin-C Liquid, TYVASO, OFEV, TEZSPIRE, JASCAYD, WINREVAIR.
Industry payments across IA — which companies pay providers there.
